Cancer Risk Amongst Children with HIV Exposure Perinatally
Researchers reviewed cancer rates in New Jersey children who were given ARVs as a result of HIV exposure compared those who were not given ARVs. Rates of cancer were not significantly higher in those children that were administered ARVs and were not different than can be expected from state and national reference rates. ARVs should continue to be administered to infants with HIV exposure to reduce the risk of transmission.
Citation:
Ivy W 3rd, Nesheim SR, Paul S, Ibrahim A, Chan M, Niu X, Lampe MA. Cancer among children with perinatal exposure to HIV and antiretroviral medications - New Jersey, 1995-2010. J Acquir Immune Defic Syndr. 2015 May 21. [Epub ahead of print].
Original Article (subscription may be required)
